MedTrace Logo

Uromodulin in Rheumatoid Arthritis

NCT03972098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2019-06-03

No results posted yet for this study

Summary

The aim of the present study was to evaluate the levels of uromodulin in rheumatoid arthritis (RA) and to investigate whether it was correlated with baseline clinical characteristics. In addition CKD epi,MDRD,urine microalbuminuria,pH,serum urea, creatinine,CRP (C-Reactive protein) were measured.The participants consist of ; %68 patients,% 32 control group.

Conditions

Sponsors & Collaborators

  • neval aksoy

    lead OTHER

Principal Investigators

  • neval aksoy, MD · Sağlık Bilimleri Universty

  • lüfiye aytüre, MD · sağlık Bilimleri Universty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-05-01
Completion
2018-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03972098 on ClinicalTrials.gov